Mission Bio
BD Biosciences runs the Rhapsody multi-omics platform, and Mission Bio's Tapestri reads somatic DNA mutations and proteins per cell, used to monitor leukaemia therapy.
- Country
- United States
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Single-cell omics | bioinformatics-omics | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.